Citations 471

O3‐10‐03: SEX AND APOE EFFECTS ON MEMORY PERFORMANCE, NEURODEGENERATION, AND B‐AMYLOID ACROSS THE ADULT LIFESPAN

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2014.04.325

APOE ε4 influences β‐amyloid deposition in primary progressive aphasia and speech apraxia

Alzheimer's & Dementia | June 28, 2014 | Volume: 10 | Issue: 6 | Pages: 630-636

10.1016/j.jalz.2014.03.004 | PMID 24985533

AbstractBackgroundApolipoprotein E ε4 (APOE ε4) is a risk factor for β‐amyloid deposition in Alzheimer's disease dementia. Its influence on β‐amyloid deposition in speech and language disorders, including primary progressive aphasia (PPA), is unclear.MethodsOne hundred thirty subjects with PPA or progressive speech apraxia underwent APOE genotyping and Pittsburgh compound B (PiB) PET scanning. The relationship between APOE ε4 and PiB status, as well as severity and regional distribution of PiB, was assessed.ResultsForty‐five subjects had an APOE ε4 allele and 60 subjects were PiB‐positive. The odds ratio for a subject with APOE ε4 being PiB‐positive compared with a subject without APOE ε4 being PiB‐positive was 10.2 (95% confidence interval, 4.4–25.5; P < .0001). The APOE ε4 allele did not influence regional PiB distribution or severity.ConclusionAPOE ε4 increases the risk of β‐amyloid deposition in PPA and progressive speech apraxia but does not influence regional β‐amyloid distribution or severity.
Association of Lifetime Intellectual Enrichment With Cognitive Decline in the Older Population

JAMA Neurology | June 23, 2014 | Volume: 71 | Issue: 8 | Pages: 1017

10.1001/jamaneurol.2014.963 | PMID 25054282

Nonverbal oral apraxia in primary progressive aphasia and apraxia of speech

Neurology | April 12, 2014 | Volume: 82 | Issue: 19 | Pages: 1729-1735

10.1212/wnl.0000000000000412 | PMID 24727315

Quantitative application of the primary progressive aphasia consensus criteria

Neurology | March 6, 2014 | Volume: 82 | Issue: 13 | Pages: 1119-1126

10.1212/wnl.0000000000000261 | PMID 24598709

Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study

Neurology | December 27, 2013 | Volume: 82 | Issue: 1 | Pages: 70-76

10.1212/01.wnl.0000438229.56094.54 | PMID 24371306

Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia

European Journal of Neurology | December 16, 2013 | Volume: 21 | Issue: 7 | Pages: 1040-1043

10.1111/ene.12331 | PMID 24330306

Background and purposeA subset of patients with Alzheimer's disease (AD) present with early and prominent language deficits. It is unclear whether the burden of underlying β‐amyloid pathology is associated with language or general cognitive impairment in these subjects.MethodsThe relationship between cortical β‐amyloid burden on [11C]Pittsburgh compound B (PiB) positron emission tomography (PET) and performance on the Montreal Cognitive Assessment (MoCA), the Wechsler Memory Scale − Third Edition (WMS‐III), the Boston Naming Test (BNT) and the Western Aphasia Battery (WAB) was assessed using regression and correlation analyses in subjects presenting with aphasia who showed β‐amyloid deposition on PiB PET.ResultsThe global PiB ratio was inversely correlated with MoCA (P = 0.02) and the WMS‐III Visual Reproduction (VR) subtest (VR I, P = 0.02; VR II, P = 0.04). However, the correlations between PiB ratio, BNT (P = 0.13), WAB aphasia quotient (P = 0.11) and WAB repetition scores (P = 0.34) were not significant.ConclusionThis study demonstrates that an increased cortical β‐amyloid burden is associated with cognitive impairment, but not language deficits, in AD subjects presenting with aphasia. The results suggest that β‐amyloid deposition could be partly contributing to impaired cognition in such patients whilst language dysfunction may be more influenced by other pathological mechanisms, perhaps downstream pathways of β‐amyloid deposition.
IC‐P‐066: Structural and functional connectivity in the logopenic variant of primary progressive aphasia and a comparison with dementia of the Alzheimer's type

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.063

O4–02–05: Combinations of amyloid and neurodegeneration biomarkers have a differential impact on cognition

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2013.04.344

P1–282: Effect of APOE and family history of dementia on Alzheimer's disease imaging biomarkers in cognitively normal subjects

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2013.05.507